161 related articles for article (PubMed ID: 34130587)
1. MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).
Geng X; Sun Y; Fu J; Cao L; Li Y
Bioengineered; 2021 Dec; 12(1):2713-2722. PubMed ID: 34130587
[TBL] [Abstract][Full Text] [Related]
2. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma.
Zang CS; Huang HT; Qiu J; Sun J; Ge RF; Jiang LW
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4890-4900. PubMed ID: 32432752
[TBL] [Abstract][Full Text] [Related]
3. Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.
Wang L; Shen YF; Shi ZM; Shang XJ; Jin DL; Xi F
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28703321
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
5. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling.
Zheng X; Rui S; Wang XF; Zou XH; Gong YP; Li ZH
J Exp Clin Cancer Res; 2021 May; 40(1):157. PubMed ID: 33962657
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
8. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
[TBL] [Abstract][Full Text] [Related]
9. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract][Full Text] [Related]
10. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.
Zhao X; Sun Z; Li H; Jiang F; Zhou J; Zhang L
Cancer Biomark; 2017 Aug; 20(2):207-216. PubMed ID: 28869452
[TBL] [Abstract][Full Text] [Related]
11. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma.
Shi D; Wang H; Ding M; Yang M; Li C; Yang W; Chen L
Onco Targets Ther; 2019; 12():6605-6616. PubMed ID: 31496749
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
Ma S; Jia W; Ni S
Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
[TBL] [Abstract][Full Text] [Related]
14. Silencing long non-coding RNA MIAT ameliorates myocardial dysfunction induced by myocardial infarction
Cao X; Ma Q; Wang B; Qian Q; Liu N; Liu T; Dong X
Aging (Albany NY); 2021 Mar; 13(8):11188-11206. PubMed ID: 33819189
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA HOTAIR promotes cell viability, migration and invasion in thyroid cancer cells by sponging miR-17-5p.
Liu X; Liu G; Lu Y; Shi Y
Neoplasma; 2020 Mar; 67(2):229-237. PubMed ID: 31607138
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-574-5p directly targets FOXN3 to mediate thyroid cancer progression via Wnt/β-catenin signaling pathway.
Zhang ZJ; Xiao Q; Li XY
Pathol Res Pract; 2020 Jun; 216(6):152939. PubMed ID: 32284251
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
18. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
19. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]